Back to search
Hepatitis, Autoimmune
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatitis, Autoimmune trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatitis, Autoimmune trials you may qualify forThis is a single-center, proof-of-concept pilot study which uses a cross-over design to compare two dietary interventions/treatments: Western Diet (WD) vs Medit…
Background: Autoimmune hepatitis (AIH) is a rare chronic and lifelong liver disease. Untreated, disease progresses to end-stage cirrhosis and the focus of thera…
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathog…
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differe…
There is a significant unmet need for safe and effective therapeutic approaches to prevent immune-mediated graft injury and its complications in liver transplan…
Identify specific blood biomarkers for hepatitis induced by immune checkpoint inhibitors in comparison to idiopathic autoimmune hepatitis.
The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag
VAY736 dose testing; VAY736 efficacy and safety testing.
The 5th International Autoimmune Hepatitis Group (IAIHG) research workshop emphasized the integration of large clinical cohorts with artificial intelligence (AI…